FDA and EMA clinical research guidelines: Assessment of trial design recommendations for pivotal psychiatric drug trials (Protocol) — Kim Boesen (2020) | RDL Network
This is a protocol for the project entitled "FDA and EMA clinical research guidelines: Assessment of trial design recommendations for pivotal psychiatric drug trials".
An‐Wen Chan, Jennifer Tetzlaff, Douglas G. Altman, Peter C Gøtzsche, Kay Dickersin, Jesse A. Berlin, Caroline J Doré, Wendy R. Parulekar, William Summerskill, Trish Groves, Kenneth F. Schulz, Frank W. Rockhold, David Moher
An‐Wen Chan, Jennifer Tetzlaff, Douglas G. Altman, Andreas Laupacis, Peter C Gøtzsche, Karmela Krleža-Jerić, Asbjørn Hróbjartsson, Howard Mann, Kay Dickersin, Jesse A. Berlin, Caroline J Doré, Wendy R. Parulekar, William Summerskill, Trish Groves, Kenneth F. Schulz, Harold C. Sox, Frank W. Rockhold, Drummond Rennie, David Moher
An‐Wen Chan, Jennifer Tetzlaff, Douglas G. Altman, A. Laupacis, P. C Gotzsche, Karmela Krleža-Jerić, Asbjørn Hróbjartsson, H Mann, Kay Dickersin, J A Berlin, Caroline J Doré, Wendy R. Parulekar, Wsm Summerskill, Trish Groves, Ken Schulz, Hal C. Sox, Frank W. Rockhold, Monique Y. Rennie, David Moher
An Wen Chan, Jennifer Tetzlaff, Douglas G. Altman, Andreas Laupacis, Peter C Gøtzsche, Karmela Krleža-Jerić, Asbjørn Hróbjartsson, Howard Mann, Kay Dickersin, Jesse A. Berlin, Caroline J Doré, Wendy R. Parulekar, William Summerskill, Trish Groves, Kenneth F. Schulz, Harold C. Sox, Frank W. Rockhold, Drummond Rennie, David Moher
Discussion(0)
No comments yet. Be the first to comment.